KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Novavax (NVAX) over the last 15 years, with Q3 2025 value amounting to $100.5 million.

  • Novavax's Change in Acquisitions & Divestments fell 483.59% to $100.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $593.1 million, marking a year-over-year increase of 46158.11%. This contributed to the annual value of $443.6 million for FY2024, which is N/A changed from last year.
  • Novavax's Change in Acquisitions & Divestments amounted to $100.5 million in Q3 2025, which was down 483.59% from $111.6 million recorded in Q2 2025.
  • In the past 5 years, Novavax's Change in Acquisitions & Divestments registered a high of $337.9 million during Q4 2024, and its lowest value of $2.2 million during Q2 2021.
  • Its 3-year average for Change in Acquisitions & Divestments is $122.6 million, with a median of $105.6 million in 2024.
  • As far as peak fluctuations go, Novavax's Change in Acquisitions & Divestments tumbled by 9243.7% in 2021, and later plummeted by 483.59% in 2025.
  • Novavax's Change in Acquisitions & Divestments (Quarter) stood at $2.2 million in 2021, then skyrocketed by 14919.73% to $337.9 million in 2024, then plummeted by 70.26% to $100.5 million in 2025.
  • Its last three reported values are $100.5 million in Q3 2025, $111.6 million for Q2 2025, and $43.0 million during Q1 2025.